GEODE CAPITAL MANAGEMENT, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 41 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$1,753,000
-31.9%
7,615,258
+5.8%
0.00%
Q4 2021$2,575,000
-42.3%
7,200,611
-3.0%
0.00%
-100.0%
Q3 2021$4,462,000
-27.2%
7,423,326
+34.4%
0.00%0.0%
Q2 2021$6,129,000
+65.3%
5,521,734
+90.6%
0.00%0.0%
Q1 2021$3,707,000
+494.1%
2,896,717
+213.2%
0.00%
Q4 2020$624,000
+3.7%
924,830
+28.9%
0.00%
Q3 2020$602,000
+826.2%
717,710
+573.2%
0.00%
Q2 2020$65,000
+10.2%
106,619
+26.2%
0.00%
Q1 2020$59,00084,4720.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 734,477$441,0000.04%
GSA CAPITAL PARTNERS LLP 516,218$310,0000.03%
Game Plan Financial Advisors, LLC 27,216$16,0000.01%
MONECO Advisors, LLC 35,000$21,0000.01%
Purus Wealth Management, LLC 15,000$9,0000.01%
Renaissance Technologies 6,038,664$3,630,0000.01%
Qube Research & Technologies Ltd 540,878$325,0000.00%
D. E. Shaw & Co., Inc. 6,690,867$4,022,0000.00%
Cutter & CO Brokerage, Inc. 19,000$11,0000.00%
Van Hulzen Asset Management, LLC 18,200$11,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders